The variant occurs on the fibronectin 1 (FN1) gene, which expresses fibronectin, an adhesive glycoprotein that lines the ...

Researchers at Columbia University have identified a genetic variant that may lower the risk of Alzheimer's disease by as much as 70%, potentially protecting thousands of people across the United ...

In a recent study, researchers suggest that a newly identified genetic variant may protect against Alzheimer's disease, ...

The study, "Rare genetic variation in Fibronectin 1 (FN1) protects against APOEε4 in Alzheimer's disease," was published ...

The gene of interest here is involved in the production of fibronectin, an important component of the blood-brain barrier that controls the movement of substances in and out of the brain.

Targeting anti-cancer therapy to affect cancer cells but not healthy cells is challenging. For chimeric antigen receptor (CAR ...

A gene mutation that reduces the odds of developing Alzheimer’s disease by 70% has been discovered by scientists. This “protective” variant occurs in a gene – FN1 – which makes a protein known as ...

The found a common variant shared by many of these people. It occurred in a gene charged with making fibronectin, a component used to make the "blood-brain barrier." That's the lining that ...

A super gene that may lower the risk of developing Alzheimer’s disease (AD) by as much as 70 per cent has been identified by ...

The discovery of a gene variant that rids the brain of toxic plaques linked to Alzheimer's might lead to new treatments for the disease, researchers report. The variant arises naturally in people ...

Blaustein and colleagues concluded that activation of the PI 3-kinase signaling pathway by Ras(V12-C40) in turn activated AKT kinase, resulting in a change in the fibronectin splicing pattern to ...

Diffuse (interstitial) lung disease includes a wide variety of relatively uncommon conditions presenting with characteristic clusters of clinical features and marked by an immune response. There ...